Literature DB >> 20082639

Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens.

Fabrice Atassi1, Alain L Servin.   

Abstract

The mechanism underlying the killing activity of Lactobacillus strains against bacterial pathogens appears to be multifactorial. Here, we investigate the respective contributions of hydrogen peroxide and lactic acid in killing bacterial pathogens associated with the human vagina, urinary tract or intestine by two hydrogen peroxide-producing strains. In co-culture, the human intestinal strain Lactobacillus johnsonii NCC933 and human vaginal strain Lactobacillus gasseri KS120.1 strains killed enteric Salmonella enterica serovar Typhimurium SL1344, vaginal Gardnerella vaginalis DSM 4944 and urinary tract Escherichia coli CFT073 pathogens. The cell-free culture supernatants (CFCSs) produced the same reduction in SL1344, DSM 4944 and CFT073 viability, whereas isolated bacteria had no effect. The killing activity of CFCSs was heat-stable. In the presence of Dulbecco's modified Eagle's minimum essential medium inhibiting the lactic acid-dependent killing activity, CFCSs were less effective at killing of the pathogens. Catalase-treated CFCSs displayed a strong decreased activity. Tested alone, hydrogen peroxide triggered a concentration-dependent killing activity against all three pathogens. Lactic acid alone developed a killing activity only at concentrations higher than that present in CFCSs. In the presence of lactic acid at a concentration present in Lactobacillus CFCSs, hydrogen peroxide displayed enhanced killing activity. Collectively, these results demonstrate that for hydrogen peroxide-producing Lactobacillus strains, the main metabolites of Lactobacillus, lactic acid and hydrogen peroxide, act co-operatively to kill enteric, vaginosis-associated and uropathogenic pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20082639     DOI: 10.1111/j.1574-6968.2009.01887.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  40 in total

Review 1.  Bacteriocin production: a probiotic trait?

Authors:  Alleson Dobson; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2011-10-28       Impact factor: 4.792

Review 2.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

Review 3.  Effects and immune responses of probiotic treatment in ruminants.

Authors:  Sarah Raabis; Wenli Li; Laura Cersosimo
Journal:  Vet Immunol Immunopathol       Date:  2019-01-06       Impact factor: 2.046

4.  Lactobacillus iners-dominated vaginal microbiota is associated with increased susceptibility to Chlamydia trachomatis infection in Dutch women: a case-control study.

Authors:  Robin van Houdt; Bing Ma; Sylvia M Bruisten; Arjen G C L Speksnijder; Jacques Ravel; Henry J C de Vries
Journal:  Sex Transm Infect       Date:  2017-09-25       Impact factor: 3.519

Review 5.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

Review 6.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

Review 7.  Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration.

Authors:  Wenly Ruan; Melinda A Engevik; Jennifer K Spinler; James Versalovic
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

8.  Oxidants in Physiological Processes.

Authors:  Ulla G Knaus
Journal:  Handb Exp Pharmacol       Date:  2021

Review 9.  Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.

Authors:  Christiane S Hampe; Christian L Roth
Journal:  Endocrine       Date:  2017-10-19       Impact factor: 3.633

Review 10.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.